Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Research>JPM Removes AKESO from Positive Catalyst Watch; Rating Kept Overweight
Recommend 9 Positive 7 Negative 6 |
||||
|
||||
|
JPMorgan has announced that it had removed AKESO (09926.HK) from its Positive Catalyst Watch. The catalyst was the release of overall survival hazard ratio data from the HARMONi-2 trial. Probably because of profit-taking, AKESO's stock price fell by about 12% on Monday (28th), after having risen by more than 15% since the end of March. The broker reiterated an Overweight rating on AKESO and named it as its top pick among China biotech stocks. Its target price remained at $110. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
